Vivos Therapeutics Stock (NASDAQ:VVOS)
Previous Close
$0.39
52W Range
$0.36 - $5.69
50D Avg
$0.55
200D Avg
$1.50
Market Cap
$2.32M
Avg Vol (3M)
$1.65M
Beta
6.12
Div Yield
-
VVOS Company Profile
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
VVOS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Treatment Centers | $2.18M | - | - |
| Service | $10.96M | $7.16M | - |
| Product | $6.49M | $7.87M | - |
| Billing Intelligence Services | $686.00K | $840.00K | - |
| Appliances | $3.28M | $5.60M | - |
| VIP | $491.00K | $2.48M | - |
| Sponsorship Seminar Other | $1.22M | $1.94M | - |
| Center Revenue | - | - | $189.00K |
Fiscal year ends in Dec 25 | Currency in USD